April 2026

Preventing the most common complication after heart surgery | When bioprosthetic valves fail | Good news for Medtronic ()
PFA's dominance & other key EP trends | FDA approves next-gen mitral valve | Virtual nursing helps practices combat burnout ()
FDA's new device warning | How to implement AI-powered coronary plaque software | Key approvals for Abbott | IV fluids recalled ()
New SCAI president outlines focus into 2027 | DCBs have similar outcomes to DES | GLP-1s lower AFib ()
‘Father of modern cardiology’ dies at 96 | High-risk women missing out on care | Tirzepatide beneficial for TAVR & PCI patients ()
Week in Review: Cardiologist pay climbs 10% | Energy drinks & heart disease | CMS, FDA propose major change | Treating HFmrEF ()
Strokes after PFA | Hospital sues practice | FDA approves fast-acting drug for children | The cardiologist shortage continues ()
CMS & FDA propose major Medicare changes | Big news for Biotronik | New imaging data on MINOCA | The first procedure of its kind ()
News Alert: Trump administration moves to speed up Medicare coverage for breakthrough devices ()
Experts agree: HFmrEF should not be ignored | Cardiologist makes 'Magic' with new device | When bioprosthetic mitral valves fail ()
A new warning for cath labs | The push for better safety standards | Major recalls | FDA clears next-gen imaging system ()
The most common complication after heart surgery | Evolocumab makes an impact | New DCB data | Medtronic leads $100M investment ()
Heart Rhythm 2026 | The cardiovascular safety of new weight loss pill | Rethinking PCI timing | FDA clears hybrid imaging system ()
PVL after TTVR | Early SAVR in asymptomatic patients | AI for mitral valve repair | Surgical valve makes US debut ()
Cardiologist pay climbs 10% | Lawsuit blames teen's death on energy drinks | Practice opens walk-in clinic | Early SAVR ()
Top 10 most popular cardiology video interviews this past month ()
Week in Review: Heartflow sues Cleerly | PFA & strokes | FDA's warning for cath labs | Stryker & Stereotaxis make moves ()
Voice-based AI for heart failure | FDA confirms another Impella recall | New gene therapy shows promise ()
FDA approves fast-acting heart drug for children | New safety data on LAAO | AI gets added value out of routine CT scans ()
Neurosurgeon treats stroke patient 120 miles away | Stereotaxis, Stryker make big moves | FDA's catheter warning | New AI for PE ()
Strokes after PFA | FDA links weight loss pill to cardiovascular risks | Stereotaxis to acquire Robocath | Antidepressants & SCD ()
Heartflow sues Cleerly | Outgoing SCAI president reflects on a busy year | FDA clears next-generation heart device ()
Heartflow sues AI rival Cleerly | Turning data into actionable insights | FDA clears new algorithms | Key innovations at ACC.26 ()
FDA's warning for cath labs | Stryker to acquire IVL company | New data on resistant hypertension | More patients, fewer doctors ()
Fraud allegations lead to $4.75M settlement | Hospital sues cardiology practice | A new business model | Whoop raises $575M ()
FDA clears AI for cardiac amyloidosis | SVS works to improve vascular care | Paravalvular leak after TTVR ()
Week in Review: Cardiologist says he was fired for speaking out | Millions of devices recalled | Hospital sues practice ()
A new approval for smallest defibrillation lead of its kind | Post-TAVR bleeding | Key details about reprocessed catheter recall ()
Medline recalls millions of devices due to safety risk | FDA's warning about sizing catheters | Post-TAVR bleeding events ()
Fighting for new cath lab safety standards | FDA confirms Impella recall | ‘Practice-changing’ research | Heart failure & PCI ()
New gene therapy targets a challenging condition | Big news out of Mount Sinai | First patients treated in PFA trial ()
TAVR Highlights: AI alerts make a big impact | When PCI can wait | A key FDA approval | New stroke prevention tech | AKI risks ()
New tricuspid valve OK for US trial | Drug shows clear long-term cardiac amyloid survival | Faster PFA ablations ()
FDA clears new software for mitral valve repair | AI-powered CCTA assessments vs. IVUS | Safety in the cath lab ()
Cardiology practice pays $3.5M in data breach settlement | Key ACC trials | More screening, treatment needed for CKD ()
Software errors lead to major insulin pump recall | FDA approves another GLP-1 pill | Premature menopause & the heart ()
Hospital sues cardiology practice | Cardiologist fired for speaking out, lawsuit claims | FDA approves another GLP-1 pill ()
Week in Review: ‘Practice-changing’ cardiology research | Another Impella recall | FDA clears AI for pulmonary hypertension ()
Innovations at ACC 2026 | Lower drug costs increase medication compliance | TAVR temporary pacing lead cleared by FDA ()
March's Top Stories: 40 Under 40 | Court affirms death sentence for Texas nurse | Recreational Adderall use | TAVR innovation ()
Key takeaways from ACC.26 | FDA confirms recall for heart pumps | AI alerts deliver value | Practice adds in-house smart lab ()
Why many surgeons want a career change | New off-the-shelf conduit for CABG shows promise | AI for CHG ()
News Alert: FDA confirms another recall for Impella heart pumps ()
TAVR in CAD patients: A new approach | Roxana Mehran elected ACC president | Wearable tech company raises $575M ()